Skip to main content

Intensity Therapeutics, Inc 10-Q/A for FY2023 Q2

Intensity Therapeutics, Inc. (INTS)

10-Q/A 2023-08-14 For: 2023-06-30
View Original
Added on April 06, 2026

About this 10-Q/A

Intensity Therapeutics, Inc filed this 10-Q/A on August 14, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).

Headline figures

Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$3.7M
compared with a net loss of $1.93M a year earlier
Diluted EPS
-$1.43
compared with -$0.57 a year earlier